result 47501 件
| JaLCDOI | 10.18926/AMO/56465 |
|---|---|
| FullText URL | 73_1_91.pdf |
| Abstract | In the article by Takase K et al. entitled “High-dose Dexamethasone Therapy as the Initial Treatment for Idiopathic Thrombocytopenic Purpura: Protocol for a Multicenter, Open-label, Single Arm Trial”, which appeared in the December 2018 issue, Vol.72, No.2, pp197-201, regarding the authors’ information in the first page, following corrections should be added as below. |
| Amo Type | Errata |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 91 |
| End Page | 91 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| JaLCDOI | 10.18926/AMO/56464 |
|---|---|
| FullText URL | 73_1_85.pdf |
| Author | Abe, Yoshiyuki| Fujibayashi, Kazutoshi| Nishizaki, Yuji| Yanagisawa, Naotake| Nojiri, Shuko| Nakano, Soichiro| Tada, Kurisu| Yamaji, Ken| Tamura, Naoto| |
| Abstract | Pneumocystis pneumonia (PCP) due to Pneumocystis jirovecii infection is the leading cause of fatal opportunistic infections in immunocompromised patients. We will determine whether a daily sulfamethoxazole-trimethoprim (SMX/TMP) dose of 200/40 mg was non-inferior to 400/80 mg for PCP prevention in patients with systemic rheumatic disease under immunosuppressive therapy. This is a randomized, open-label, multicenter controlled trial. The primary outcome is the rate of PCP prevention at 52 weeks. The secondary outcome is the discontinuation rate of SMX/TMP. The trial will evaluate the optimal dose of SMX/TMP for PCP prevention in patients with systemic rheumatic disease under immunosuppressive therapy. |
| Keywords | pneumocystis pneumonia prophylaxis systemic rheumatic disease sulfamethoxazole-trimethoprim conventional-dose versus half-dose |
| Amo Type | Clinical Study Protocol |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 85 |
| End Page | 89 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 30820060 |
| JaLCDOI | 10.18926/AMO/56463 |
|---|---|
| FullText URL | 73_1_81.pdf |
| Author | Sugihara, Yuusaku| Harada, Keita| Oka, Shohei| Yasutomi, Eriko| Yamasaki, Yasushi| Inokuchi, Toshihiro| Kinugasa, Hideaki| Takahara, Masahiro| Hiraoka, Sakiko| Otsuka, Fumio| Okada, Hiroyuki| |
| Abstract | Endoscopic submucosal dissection (ESD) is reportedly one of the standard treatment strategies for large superficial colorectal neoplasms in Japan because of its high en bloc resection rate. A few technical issues regarding ESD should be considered, one of which is the selection of the Endo-cut I mode versus the Swift-coagulation mode as the electrosurgical unit mode setting during submucosal dissection. We seek to determine which of these two modes is more suitable for submucosal dissections of colorectal tumors with regard to procedure time and safety. |
| Keywords | endoscopic submucosal dissection electrosurgical mode colorectal tumor |
| Amo Type | Clinical Study Protocol |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 81 |
| End Page | 84 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 30820059 |
| JaLCDOI | 10.18926/AMO/56462 |
|---|---|
| FullText URL | 73_1_77.pdf |
| Author | Morita, Mio| Matsumoto, Hiroshi| Shirakawa, Yasuhiro| Noma, Kazuhiro| Tanabe, Shunsuke| Kimata, Yoshihiro| |
| Abstract | Anterior cervical plate fixation is a common surgical treatment for cervical spine trauma, disc herniation, or cervical spondylosis. Esophageal perforation following anterior cervical plate fixation is a rare but serious complication. Management of esophageal perforation is controversial; however, we suggest treating most cases surgically because this condition is slow to heal and often fatal. We managed 2 cases of esophageal perforation following anterior cervical plate fixation by flap reconstruction with the pectoralis major muscle in one case and a jejunal free flap in the other. Here, we report our experience and review the surgical indications. |
| Keywords | anterior cervical plate fixation esophageal perforation reconstruction pectoralis major flap jejunal free flap |
| Amo Type | Case Report |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 77 |
| End Page | 80 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 30820058 |
| JaLCDOI | 10.18926/AMO/56461 |
|---|---|
| FullText URL | 73_1_71.pdf |
| Author | Takahashi-Arimasa, Keiko| Kohno-Yamanaka, Reiko| Soga, Yoshihiko| Miura, Rumi| Morita, Manabu| |
| Abstract | Preoperative oral care is helpful to prevent postoperative complications in patients who are undergoing esophagectomy. Here, we report the case of an 81-year-old Japanese man with an upper limb disability caused by post-polio syndrome who was receiving neoadjuvant chemotherapy for esophageal cancer. He had poor oral health status and developed oral complications as a side effect of chemotherapy. He could not brush his teeth by himself. However, infection control by oral care provided by an interprofessional collaboration successfully improved his oral hygiene, and his follow-up involved no severe complications. Interprofessional collaboration is useful especially for patients with upper limb disability. |
| Keywords | esophageal cancer preoperative oral care post-polio syndrome neoadjuvant chemotherapy oral mucositis |
| Amo Type | Case Report |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 71 |
| End Page | 76 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 30820057 |
| JaLCDOI | 10.18926/AMO/56460 |
|---|---|
| FullText URL | 73_1_67.pdf |
| Author | Kono, Reika| Shimizu, Takehiro| Ohtsuki, Hiroshi| Hamasaki, Ichiro| Shibata, Kiyo| Kishimoto, Fumiko| Morizane, Yuki| Shiraga, Fumio| |
| Abstract | We report a case of congenital multiple ocular motor nerve palsy combined with splitting of the lateral rectus muscle (LR). A 59-year-old Japanese female was investigated for worsening esotropia after corrective surgery. She presented with left hypertropia (35Δ) and esotropia (45-50Δ). Orbital magnetic resonance imaging (MRI) showed reduced belly sizes in the superior rectus, inferior rectus, and superior oblique muscles and splitting of the LR, extending from the origin to the belly, in the left eye. Splitting of the LR belly was detected on MRI in a case of congenital multiple ocular motor nerve palsy. |
| Keywords | multiple ocular motor nerve palsy congenital cranial dysinnervation disorder lateral rectus muscle splitting orbital connective tissue magnetic resonance imaging |
| Amo Type | Case Report |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 67 |
| End Page | 70 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 30820056 |
| JaLCDOI | 10.18926/AMO/56459 |
|---|---|
| FullText URL | 73_1_61.pdf |
| Author | Tamefusa, Kosuke| Ishida, Hisashi| Washio, Kana| Ishida, Toshiaki| Morita, Hirosuke| Shimada, Akira| |
| Abstract | Patients with multi-system (MS)-type langerhans cell histiocytosis (LCH) show poor outcomes, especially congenital MS LCH cases were shown in high mortality rate. We experienced a congenital case of MS LCH with high risk organs, who needed intensive respiratory support after birth. Even though intensive chemotherapy was discontinued, this patient’s lung LCH lesions gradually became reduced and his respiratory condition recovered; therefore, we restarted and completed maintenance chemotherapy. The patient maintained complete remission for more than 4 years after the end of chemotherapy. Our case suggests that congenital MS LCH even with severe organ involvement can be treated successfully with chemotherapy. |
| Keywords | Langerhans-cell histiocytosis congenital multisystem type |
| Amo Type | Case Report |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 61 |
| End Page | 65 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 30820055 |
| JaLCDOI | 10.18926/AMO/56458 |
|---|---|
| FullText URL | 73_1_51.pdf |
| Author | Fujii, Masakuni| Fujimoto, Kenji| Yabe, Syuntaro| Nasu, Junichiro| Miyaike, Jiro| Yoshioka, Masao| Shiode, Junji| Yamamoto, Kazuhide| Matsuda, Shinya| |
| Abstract | We investigated the relationship between body mass index (BMI) and postoperative outcomes in 450 gallbladder cancer patients in Japan. We collected patient information, including sex, age, underlying disease, BMI, stage, surgery method, postoperative time to discharge, and postoperative Medicare fees, from the Japanese administrative database associated with the Diagnosis Procedure Combination system. We classified patient BMIs as underweight (BMI<18.5 kg/m2), normal (BMI≥18.5 kg/m2 and <25 kg/m2) or overweight/obese (BMI≥25 kg/m2), then investigated the relationship between these categories and two postoperative outcomes: time to discharge and postoperative Medicare fees. The median postoperative time to discharge was 12 days in all patients, and 12 days in each of the three weight groups (p=0.62, n.s.). The median postoperative Medicare fees from surgery until discharge were (USD): all patients, $5,002; underweight, $5,875; normal weight, $4,797; and overweight/obese, $5,179 (p=0.146, n.s.). A multivariate analysis with adjustment for competing risk factors revealed that BMI was not associated with increased risk of longer postoperative time to discharge (normal weight: HR 1.17, p=0.29; overweight/obese: HR 1.17, p=0.37) or higher postoperative Medicare fees (OR 0.99, p=0.86, n.s.). Thus, high BMI was not found to be a factor for poor postoperative outcomes in Japanese patients with gallbladder cancer. |
| Keywords | body mass index gallbladder cancer surgery obesity |
| Amo Type | Original Article |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 51 |
| End Page | 59 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 30820054 |
| JaLCDOI | 10.18926/AMO/56457 |
|---|---|
| FullText URL | 73_1_43.pdf |
| Author | Ikeda, Ailee| Takaki, Akinobu| Yasunaka, Tetsuya| Oyama, Atsushi| Adachi, Takuya| Wada, Nozomu| Onishi, Hideki| Ikeda, Fusao| Shiraha, Hidenori| Yoshida, Kazuhiro| Kuise, Takashi| Nobuoka, Daisuke| Yoshida, Ryuichi| Umeda, Yuzo| Yagi, Takahito| Fujiwara, Toshiyoshi| Okada, Hiroyuki| |
| Abstract | Post-orthotopic liver transplantation (OLT) hepatitis B recurrence is well-controlled with a nucleos(t)ide analogue and hepatitis B immunoglobulin (HBIG) combination, but the high cost and the potential risk of unknown infection associated with HBIG remain unresolved issues. Low-cost recombinant hepatitis B virus (HBV) vaccine administration is a potential solution to these problems. We retrospectively analyzed the rate and predictive factors of HBV vaccine success in 49 post-OLT patients: liver cirrhosis-type B (LC-B), n=28 patients; acute liver failure-type B (ALF-B), n=8; and non-HBV-related end-stage liver disease (non-B ESLD) who received a liver from anti-hepatitis B core antibody-positive donors, n=13. A positive anti-hepatitis B surface antibody response was achieved in 29% (8/28) of the LC-B group, 88% (7/8) of the ALF-B group, and 44% (4/9) of the adult non-B ESLD group. All four non-B ESLD infants showed vaccine success. The predictive factors for a good response in LC-B were young age, marital donor, and high donor age. ALF-B and non-B ESLD infants are thus good vaccination candidates. LC-B patients with marital donors are also good candidates, perhaps because the donated liver maintains an efficient immune memory to HBV, as the donors had already been infected in adulthood and showed adequate anti-HBV immune responses. |
| Keywords | acute liver failure hepatitis B hepatitis B vaccine liver cirrhosis liver transplantation |
| Amo Type | Original Article |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 41 |
| End Page | 50 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 30820053 |
| JaLCDOI | 10.18926/AMO/56456 |
|---|---|
| FullText URL | 73_1_29.pdf |
| Author | Matsumoto, Atsushi| Nakamura, Takehiro| Shinomiya, Aya| Kawakita, Kenya| Kawanishi, Masahiko| Miyake, Keisuke| Kuroda, Yasuhiro| Keep, Richard F.| Tamiya, Takashi| |
| Abstract | Cerebral vasospasm (CVS) is a major contributor to the high morbidity and mortality of aneurysmal subarachnoid hemorrhage (aSAH) patients. We measured histidine-rich glycoprotein (HRG), a new biomarker of aSAH, in cerebrospinal fluid (CSF) to investigate whether HRG might be an early predictor of CVS. A total of seven controls and 14 aSAH patients (8 males, 6 females aged 53.4±15.4 years) were enrolled, and serial CSF and serum samples were taken. We allocated these samples to three phases (T1-T3) and measured HRG, interleukin (IL)-6, fibrinopeptide A (FpA), and 8-hydroxy-2’-deoxyguanosine (8OHdG) in the CSF, and the HRG in serum. We also examined the release of HRG in rat blood incubated in artificial CSF. In contrast to the other biomarkers examined, the change in the CSF HRG concentration was significantly different between the nonspasm and spasm groups (p<0.01). The rat blood/CSF model revealed a time course similar to that of the human CSF samples in the non-spasm group. HRG thus appears to have the potential to become an early predictor of CVS. In addition, the interaction of HRG with IL-6, FpA, and 8OHdG may form the pathology of CVS. |
| Keywords | biomarker histidine-rich glycoprotein predictor subarachnoid hemorrhage vasospasm |
| Amo Type | Original Article |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 29 |
| End Page | 39 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 30820052 |
| reference | Sabri M, Ai J, Lakovic K and Macdonald RL: Mechanisms of microthrombosis and microcirculatory constriction after experimental subarachnoid hemorrhage. Acta Neurochir Suppl (2013) 115: 185-192.| Loch MR: Management of cerebral vasospasm. Neurosurg Rev (2006) 29: 179-193.| Vestergaard AB, Andersen HF, Magnusson S and Halkier T: Histidine-rich glycoprotein inhibits contact activation of blood coagulation. Thromb Res (1990) 60: 385-396.| MacQuarrie JL, Stafford AR, Yau JW, Leslie BA, Vu TT, Fredenburgh JC and Weitz JI: Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact initiated coagulation. Blood (2011) 117: 4134-4141.| Tsuchida-Straeten N, Ensslen S, Schafer C, Woltje M, Denecke B, Monser M, Gräber S, Wakabayashi S, Koide T and Jahnen- Dechent W: Enhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein (HRG). J Thromb Haemost (2005) 3: 865-872.| Poon IK, Hulett MD and Parish CR: Histidine-rich glycoprotein is a novel plasma pattern recognition molecule that recruits IgG to facilitate necrotic cell clearance via FcgammaRI on phagocytes. Blood (2010) 115: 2473-2482.| Doñate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel- Tsur Z, Shaw DE, Morgan WT and Mazar AP: Peptides derived fromthe histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities. Cancer Res (2004) 64: 5812-5817.| Wake H, Mori S, Liu K, Takahashi HK and Nishibori M: Histidinerich glycoprotein inhibited high mobility group box 1 in complex with heparin-induced angiogenesis inmatrigel plug assay. Eur J Pharmacol (2009) 623: 89-95.| Dixelius J, Olsson AK, Thulin A, Lee C, Johansson I and Claesson-Welsh L: Minimal active domain and mechanism of action of the angiogenesis inhibitor histidine-rich glycoprotein. Cancer Res (2006) 66: 2089-2097.| Lee C, Dixelius J, Thulin A, Kawamura H, Claesson-Welsh L and Olsson AK: Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions. Exp Cell Res (2006) 312: 2547-2556.| Shannon O, Rydengård V, Schmidtchen A, Mörgelin M, Alm P, Sørensen OE and Björck L: Histidine-rich glycoprotein promotes bacterial entrapment in clots and decreases mortality in a mouse model of sepsis. Blood (2010) 116: 2365-2372.| Wake H, Mori S, Liu K, Morioka Y, Teshigawara K, Sakaguchi M, Kuroda K, Gao Y, Takahashi H, Ohtsuka A, Yoshino T, Morimatsu H and Nishibori M: Histidine-Rich Glycoprotein Prevents Septic Lethality through Regulation of Immunothrombosis and Inflammation. EBioMedicine (2016) 9: 180-194.| Hijdra A, Brouwers PJ, Vermeulen M and van Gijn J: Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke (1990) 21: 1156-1161.| Koide T, Foster D, Yoshitake S and Davie EW: Amino acid sequence of human histidine-rich glycoprotein derived from the nucleotide sequence of its cDNA. Biochemistry (1986) 25: 2220- 2225.| Anderson GB, Ashforth R, Steinke DE and Findlay JM: CT angiography for the detection of cerebral vasospasm in patients with acute subarachnoid hemorrhage. Am J Neuroradiol (2000) 21: 1011-1015.| Brown JM, Grosso MA and Harken AH: Cytokines, sepsis and the surgeon. Surg Gynecol Obstet (1989) 169: 568-575.| Tiit M, Birger A, Annika L and Hans VH: Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg (1993) 78: 562-567.| Chaichana KL, Pradilla G, Huang J and Tamargo RJ: Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurg (2010) 73: 22- 41.| Tang QF, Lu SQ, Zhao YM and Qian JX: The changes of von willebrand factor/a disintegrin-like and metalloprotease with thrombospondin type I repeats-13 balance in aneurysmal subarachnoid hemorrhage. Int J Clin Exp Med (2015) 8: 1342-1348.| Kao HW, Lee KW, Kuo CL, Huang CS, Tseng WM, Liu CS and Lin CP: Interleukin-6 as a Prognostic Biomarker in Ruptured Intracranial Aneurysms. PLoS ONE (2015) 10: e0132115.| Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schutt S, Fritzinger M, Horn P, Vajkoczy P, Kreisel S, Brunner J, Schmiedek P and Hennerici M: Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry (2001) 70: 534-537.| Niwa A, Osuka K, Nakura T, Matsuo N, Watabe T and Takayasu M: Interleukin-6, MCP-1, IP-10, and MIG are sequentially expressed in cerebrospinal fluid after subarachnoid hemorrhage. J Neuroinflammation (2016) 13: 217.| Osuka K, Watanabe Y, Yamauchi K, Nakazawa A, Usuda N, Tokuda M and Yoshida J: Activation of the JAK-STAT signaling pathway in the rat basilar artery after subarachnoid hemorrhage. Brain Res (2006) 1072: 1-7.| Nakahara T, Tsuruta R, Kaneko T, Yamashita S, Fujita M, Kasaoka S, Hashiguchi T, Suzuki M, Maruyama I and Maekawa T: High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage. Neurocrit Care (2009) 11: 362-368.| Ni W, Gu YX, Song DL, Leng B, Li PL and Mao Y: The relationship between IL-6 in CSF and occurrence of vasospasm after subarachnoid hemorrhage. Acta Neurochir Suppl (2011) 110: 203- 208.| Osuka K, Suzuki Y, Tanazawa T, Hattori K, Yamamoto N, Takayasu M, Shibuya M and Yoshida J: Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien) (1998) 140: 943-951.| Blomback B: Fibrinogen and fibrin-proteins with complex roles in hemostasis and thrombosis. Thromb Res (1996) 83: 1-75.| Weisel JW: Fibrin assembly. Lateral aggregation and the role of the 2 pairs of fibrinopeptides. Biophys J (1986) 50: 1079-1093.| Weisel JW, Veklich Y and Gorkun O: The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. J Mol Biol (1993) 232: 285-297.| Yong JI, Meng QH and Wang ZG: Changes in the coagulation and fibrinolytic system of patients with subarachnoid hemorrhage. Neurol Med Chir (Tokyo) (2014) 54: 457-464.| Kasuya H: Complement components in cerebrospinal fluid and vasospasm after subarachnoid hemorrhage. Journal Tokyo Womanʼs Medical University (1990) 60: 63-68 (in Japanese).| Kasuya H, Shimizu T, Okada T, Takahashi K, Summerville T and Kitamura K: Activation of the coagulation system in the subarachnoid space after subarachnoid hemorrhage: Serial measurement of fibrinopeptide A and bradykinin of cerebrospinal fluid and plasma in patients with subarachnoid hemorrhage. Acta Neurochir (1988) 38 Matsumoto et al. Acta Med. Okayama Vol. 73, No. 1 91: 120-125.| Blat Y and Seiffert D: A renaissance for the contact system in blood coagulation? Thromb Haemost (2008) 99: 457-460.| Colman RW: Are hemostasis and thrombosis two sides of the same coin? J Exp Med (2006) 203: 493-495.| Kasai H: Analysis of a form of oxidative DNA damage, 8-hydroxy-2ʼ-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res (1997) 387: 147-163.| Lunec J, Holloway KA, Cooke MS, Steve F, Helen RG and Mark DE: Urinary 8-oxo2ʼ-deoxyguanosine: redox regulation of DNA repair in vivo? Free Radic Biol Med (2002) 33: 875-885.| Ayer RE and Zhang JH: Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir (Suppl) (2008) 104: 33-41.| Zhao M, Ikeda Y, Jimbo H, Fukuda A, Sugiyama K, Ishihara K and Matsumoto K: The correlation between DNA damage and cell membrane damage based on the analysis of the new oxidative stress marker in patients with subarachnoid hemorrhage. J Showa Univ Soc (2002) 62: 50-56 (in Japanese).| Mori T, Nagata K, Town T, Tan J, Matsui T and Asano T: Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model. Stroke (2001) 32: 636-642.| Steelman SM, Hein TW, Gorman A and Bix GJ: Effects of histidine- rich glycoprotein on cerebral blood vessels. J Cereb Blood Flow Metab (2013) 33: 1373-1375.| Leung LL, Harpel PC, Nachman RL and Rabellino EM: Histidinerich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood (1983) 62: 1016-1021.| Blank M and Shoenfeld Y: Histidine-rich glycoprotein modulation of immune/autoimmune, vascular, and coagulation systems. Clin Rev Allergy Immunol (2008) 34: 307-312.| |
| JaLCDOI | 10.18926/AMO/56455 |
|---|---|
| FullText URL | 73_1_21.pdf |
| Author | Oiwa, Yuko| Watanabe, Toyohiko| Sadahira, Takuya| Ishii, Ayano| Sako, Tomoko| Inoue, Miyabi| Wada, Koichiro| Kobayashi, Yasuyuki| Araki, Motoo| Nasu, Yasutomo| |
| Abstract | We measured basal clitoral blood flow by Doppler sonography to determine whether tension-free vaginal mesh(TVM) affects the clitoral blood flow and sexual function in women with pelvic organ prolapse (POP). We performed a prospective study of 22 patients who underwent TVM for POP. Clitoral blood flow was measured by Doppler ultrasound. The resistance index (RI), pulsatility index (PI), peak systolic velocity (PSV), and end-diastolic velocity (EDV) of the clitoral arteries were measured preoperatively and at 1, 3, and 6 months postoperatively. Female sexual function was also investigated with the Female Sexual Function Index (FSFI). The mean PI and RI were increased at 1 month and significantly decreased at 6 months postoperatively (p<0.05). In contrast, the mean PSV and EDV decreased at 1 month postoperatively and increased at 6 months postoperatively. These four parameters recovered to baseline levels at 6 months following surgery. Total FSFI scores improved significantly from 10.2±7.9 at baseline to 18.2±8.9 at 6 months postoperatively. Color Doppler ultrasonography is potentially useful in measuring clitoral blood flow in patients treated with TVM for POP. Prospective long-term studies are needed to evaluate the utility of this modality as a diagnostic and prognostic tool for female sexual dysfunction. |
| Keywords | clitoris pelvic organ prolapse Doppler ultrasound |
| Amo Type | Original Article |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 21 |
| End Page | 27 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 30820051 |
| JaLCDOI | 10.18926/AMO/56454 |
|---|---|
| FullText URL | 73_1_15.pdf |
| Author | Shioji, Naohiro| Kanazawa, Tomoyuki| Iwasaki, Tatsuo| Shimizu, Kazuyoshi| Suemori, Tomohiko| Kuroe, Yasutoshi| Morimatsu, Hiroshi| |
| Abstract | We compared the reintubation rate in children who received high-flow nasal cannula (HFNC) therapy to the rate in children who received noninvasive ventilation (NIV) therapy for acute respiratory failure (ARF) after cardiac surgery. This was a retrospective analysis of 35 children who received HFNC therapy for ARF after cardiac surgery in 2014-2015 (the HFNC group). We selected 35 children who had received NIV therapy for ARF after cardiac surgery in 2009-2012 as a control group. The matching parameters were body weight and risk adjustment for congenital heart surgery category 1. The reintubation rate within 48 h in the HFNC group tended to be lower than that in the NIV group (3% vs. 17%, p=0.06). The reintubation rate within 28 days was significantly lower in the HFNC group compared to the NIV group (3% vs. 26%, p=0.04). The HFNC group’s ICU stays were significantly shorter than those of the NIV group: 10 (IQR: 7-17) days vs. 17 (11-32) days, p=0.009. HFNC therapy might be associated with a reduced reintubation rate in children with ARF after cardiac surgery. |
| Keywords | high-flow nasal cannula noninvasive ventilation reintubation congenital heart disease acute respiratory failure |
| Amo Type | Original Article |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 15 |
| End Page | 20 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 30820050 |
| JaLCDOI | 10.18926/AMO/56453 |
|---|---|
| FullText URL | 73_1_7.pdf |
| Author | Fukumori, Norio| Sonohata, Motoki| Kitajima, Masaru| Kawano, Shunsuke| Kurata, Tsuyoshi| Sakanishi, Yuta| Sugioka, Takashi| Mawatari, Masaaki| |
| Abstract | We evaluated the analgesic effects of multimodal pain control in which intravenous acetaminophen (IV APAP) was added to the standard protocol for Japanese patients who had undergone a total hip arthroplasty (THA). We performed a retrospective cohort study of 180 patients aged 66.4±10.5 years (30% male) who had undergone a THA (Oct. 2014 to Feb. 2015) at our hospital. The control patients were administered the standard analgesic protocol: flurbiprofen axetil as a continuous intravenous infusion and oral celecoxib (NAPAP; n=109). The patients in the new analgesic protocol group received IV APAP in addition to the standard analgesic protocol (APAP; n=71). The primary outcome was the maximum value of postoperative pain the patients reported on a numerical rating scale (NRS) during the first 24 h post-surgery. A univariate analysis and multivariate analyses adjusted for age, sex, the stage of hip osteoarthritis, preoperative pain, and surgical time showed that the maximum postoperative pain NRS scores during the first 24 h after surgery was significantly lower when the APAP protocol was used. The addition of IV APAP to the current standard multimodal analgesia protocol for Japanese patients who have undergone a THA may decrease the patients’ postoperative pain. |
| Keywords | intravenous acetaminophen postoperative pain total hip arthroplasty osteoarthritis |
| Amo Type | Original Article |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 7 |
| End Page | 14 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 30820049 |
| JaLCDOI | 10.18926/AMO/56452 |
|---|---|
| FullText URL | 73_1_1.pdf |
| Author | Morizane, Shin| |
| Abstract | Excessive protease activity is a characteristic abnormality that affects the epidermal barrier in patients with atopic dermatitis (AD). Kallikrein-related peptidases (KLKs) are excessively expressed in AD lesions, and it is suggested that the abnormal action of KLKs is involved in the skin barrier dysfunction in AD. In other words, overexpressed KLKs disrupt the normal barrier function, and due to that breakdown, external substances that can become antigens of AD easily invade the epidermis, resulting in dermatitis, coupled with the induction of Th2 cytokines. Further investigations are required to elucidate the role of KLKs in AD; this knowledge could contribute to the design of new therapeutic and prophylactic drugs for AD. |
| Keywords | atopic dermatitis kallikrein-related peptidases epidermal barrier dysfunction |
| Amo Type | Review |
| Publication Title | Acta Medica Okayama |
| Published Date | 2019-02 |
| Volume | volume73 |
| Issue | issue1 |
| Publisher | Okayama University Medical School |
| Start Page | 1 |
| End Page | 6 |
| ISSN | 0386-300X |
| NCID | AA00508441 |
| Content Type | Journal Article |
| language | English |
| Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
| File Version | publisher |
| Refereed | True |
| PubMed ID | 30820048 |
| FullText URL | OJE_2019021915240510.pdf |
|---|---|
| Author | Kato, Sadahisa| Hishiyama, Kosuke| Anak Agung Ketut Darmadi| Ngakan Ketut Acwin Dwijendra| Dewa Ngurah Suprapta| |
| Keywords | Telajakan Bali Urban Green Spaces |
| Published Date | 2019-02-20 |
| Publication Title | Open Journal of Ecology |
| Volume | volume9 |
| Publisher | Scientific Research Publishing |
| Start Page | 15 |
| End Page | 24 |
| ISSN | 2162-1993 |
| Content Type | Journal Article |
| language | English |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | http://creativecommons.org/licenses/by/4.0/ |
| File Version | publisher |
| DOI | 10.4236/oje.2019.92002 |
| Related Url | isVersionOf https://doi.org/10.4236/oje.2019.92002 |
| FullText URL | IPSJ-Z79-7Q-08.pdf |
|---|---|
| Author | 河村 一希| Takeuchi, Koichi| |
| Published Date | 2017-03 |
| Publication Title | 情報処理学会全国大会講演論文集 |
| Volume | volume79 |
| Publisher | 情報処理学会 |
| Start Page | 607 |
| End Page | 608 |
| NCID | AN00349328 |
| Content Type | Conference Paper |
| language | Japanese |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | copyright(c)Information Processing Society of Japan |
| File Version | publisher |
| FullText URL | IPSJ-Z79-7Q-04.pdf |
|---|---|
| Author | 宮田 周| Takeuchi, Koichi| |
| Published Date | 2017-03 |
| Publication Title | 情報処理学会全国大会講演論文集 |
| Volume | volume79 |
| Publisher | 情報処理学会 |
| Start Page | 599 |
| End Page | 600 |
| NCID | AN00349328 |
| Content Type | Conference Paper |
| language | Japanese |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | copyright(c)Information Processing Society of Japan |
| File Version | publisher |
| FullText URL | Association_Natural_Language_Processing_2017.pdf |
|---|---|
| Author | Takeuchi, Koichi| 大野 雅幸| 泉仁 宏太| Taguchi, Masahiro| Inada, Yoshihiko| Iizuka, Masaya| Abo, Tatsuhiko| Ueda, Hitoshi| |
| Published Date | 2017-03 |
| Publication Title | 言語処理学会年次大会発表論文集 |
| Volume | volume23 |
| Publisher | 言語処理学会 |
| Start Page | 839 |
| End Page | 842 |
| NCID | AA11909127 |
| Content Type | Conference Paper |
| language | Japanese |
| OAI-PMH Set | 岡山大学 |
| File Version | author |
| FullText URL | Association_Natural_Language_Processing_2018.pdf |
|---|---|
| Author | Ohno, Masayuki| 泉仁 宏太| Takeuchi, Koichi| 小畑 友也| Taguchi, Masahiro| Inada, Yoshihiko| Iizuka, Masaya| 阿保 達彦| 上田 均| |
| Published Date | 2018-03 |
| Publication Title | 言語処理学会年次大会発表論文集 |
| Volume | volume24 |
| Publisher | 言語処理学会 |
| Start Page | 368 |
| End Page | 371 |
| NCID | AA11909127 |
| Content Type | Conference Paper |
| language | Japanese |
| OAI-PMH Set | 岡山大学 |
| File Version | author |
| Title Alternative | Proposing an Unsupervised Approach to Evaluate Essays Using IDF on Reference Data |
|---|---|
| FullText URL | NLC2018-33.pdf |
| Author | Ohno, Masayuki| Takeuchi, Koichi| Motojin, Kota| Obata, Yuya| Taguchi, Masahiro| Inada, Yoshihiko| Iizuka, Masaya| Abo, Tatsuhiko| Ueda, Hitoshi| |
| Keywords | 自動採点 (automatic scoring of essays) アノテーション (human annotation) 採点支援 (supporting system of essay evaluation) idf neologd |
| Published Date | 2018-12 |
| Publication Title | IEICE technical report. Natural language processing and models of communication |
| Volume | volume118 |
| Issue | issue355 |
| Publisher | 電子情報通信学会 |
| Start Page | 103 |
| End Page | 108 |
| ISSN | 09135685 |
| NCID | AA11524632 |
| Content Type | Journal Article |
| language | Japanese |
| OAI-PMH Set | 岡山大学 |
| Copyright Holders | copyright@2018 |
| File Version | publisher |
